Press releases.
Press releases 2019
Press releases 2019
INSIGHT-004 Clinical Trial Update
December 19th 2019
Immutep Announces European Patent Grant for LAG525 Antibody
November 14th 2019
Operational Update
October 28th 2019
Immutep Announces Data Presentations at Upcoming Industry Conferences
October 10th 2019
Immutep Receives A$2.5 Million R&D Tax Incentive from French Government
October 10th 2019
Immutep to Receive £4M Milestone Payment from GSK
September 23rd 2019
Immutep Announces Japanese Patent Grant for LAG525 Antibody
September 17th 2019
Immutep Granted European Patent for Eftilagimod Alpha in Cancer
August 22nd 2019
Immutep Completes A$6M Entitlement Offer
August 6th 2019
Operational Update
July 26th 2019
Immutep to Host Key Opinion Leader Call
June 24th 2019
Immutep Presentation at ASCO 2019
June 3rd 2019
Operational Update
April 30th 2019
Immutep to Present IMP761 Preclinical Results in Global Webcast
March 18th 2019
Immutep doses First Patient in TACTI-002 Phase II Trial
March 6th 2019
Immutep to Present at Upcoming Industry Conferences
February 26th 2019